Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US

OBJECTIVE: To characterize the use and safety of newer disease-modifying therapies (DMTs) in children with multiple sclerosis (MS) and clinically isolated syndrome (CIS) treated under 18 years of age. METHODS: This is a cohort study including children with MS or CIS followed at 12 outpatient practic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurology
Main Authors: Krysko, Kristen M., Graves, Jennifer, Rensel, Mary, Weinstock-Guttman, Bianca, Aaen, Gregory, Benson, Leslie, Chitnis, Tanuja, Gorman, Mark, Goyal, Manu, Krupp, Lauren, Lotze, Timothy, Mar, Soe, Rodriguez, Moses, Rose, John, Waltz, Michael, Charles Casper, T., Waubant, Emmanuelle
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6251604/
https://ncbi.nlm.nih.gov/pubmed/30333163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000006471
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados